Meritain Eldorado policies
Search Meritain Eldorado's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.
14 policies name 88341, those listing the fewest codes first. A policy that names a code may also list it as excluded.
| Policy | Details | Codes | Source |
|---|---|---|---|
| 0815-Ipilimumab (Yervoy) | 0815 · Commercial | 14 | Original policy ↗ |
| 0774-Nerve Fiber Density Measurement | 0774 · Commercial | 15 | Original policy ↗ |
| Retifanlimab-dlwr (Zynyz) | 1030 · Commercial | 23 | Original policy ↗ |
| 0939-Transthyretin-Mediated (ATTR) Amyloidosis | 0939 · Commercial | 25 | Original policy ↗ |
| Trastuzumab Products | 0313 · Commercial | 28 | Original policy ↗ |
| Salivary Tests | 0608 · Commercial | 34 | Original policy ↗ |
| 0890-Pembrolizumab Products (Keytruda and Keytruda Qlex) | 0890 · Commercial | 82 | Original policy ↗ |
| 0038-Allergy and Hypersensitivity | 0038 · Commercial | 96 | Original policy ↗ |
| Recurrent Pregnancy Loss | 0348 · Commercial | 109 | Original policy ↗ |
| 0307-Parkinson's Disease | 0307 · Commercial | 119 | Original policy ↗ |
| Genetic Testing | 0140 · Commercial | 227 | Original policy ↗ |
| 0715-Pharmacogenetic Testing | 0715 · Commercial | 231 | Original policy ↗ |
| 0648-Autism Spectrum Disorders | 0648 · Commercial | 284 | Original policy ↗ |
| Tumor Markers | 0352 · Commercial | 368 | Original policy ↗ |